HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Cong Selected Research

Neuroinflammatory Diseases

10/2020Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARα/γ dual agonist, reverses neuroinflammation in lipopolysaccharide-induced mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Cong Research Topics

Disease

7Neoplasms (Cancer)
01/2024 - 01/2020
2COVID-19
01/2021 - 01/2020
2Infections
05/2019 - 01/2019
1Epstein-Barr Virus Infections
04/2024
1Breast Neoplasms (Breast Cancer)
12/2023
1Nasopharyngeal Carcinoma
09/2023
1Hepatocellular Carcinoma (Hepatoma)
01/2023
1Liver Neoplasms (Liver Cancer)
01/2023
1Colonic Neoplasms (Colon Cancer)
11/2022
1Cicatrix (Scar)
08/2022
1Cytokine Release Syndrome
01/2021
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021
1Drug-Related Side Effects and Adverse Reactions
01/2021
1Testicular Neoplasms (Testicular Cancer)
01/2021
1Lung Neoplasms (Lung Cancer)
11/2020
1Disease Progression
11/2020
1Myeloid Leukemia (Leukemia, Myelocytic)
10/2020
1Neuroinflammatory Diseases
10/2020
1Memory Disorders (Memory Loss)
01/2020
1Thrombosis (Thrombus)
01/2020
1Ischemic Stroke
01/2020
1Fibrosis (Cirrhosis)
01/2020
1Cognitive Dysfunction
01/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018
1Adenocarcinoma of Lung
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Hemolysis
03/2016

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
09/2023 - 08/2022
2Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2020
2propane-2-sulfonic acid octadec-9-enyl-amideIBA
10/2020 - 01/2020
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2020 - 01/2020
1InterferonsIBA
04/2024
1AntigensIBA
01/2024
1AntibodiesIBA
01/2024
1Nucleic AcidsIBA
12/2023
1Estrogen ReceptorsIBA
12/2023
1Nucleotide AptamersIBA
12/2023
1Galectin 1 (LGALS1)IBA
01/2023
1CateninsIBA
11/2022
1Teniposide (VM 26)FDA Link
01/2021
1Podophyllotoxin (Condylox)FDA LinkGeneric
01/2021
1Etoposide (VP 16)FDA LinkGeneric
01/2021
1Tyrosine Kinase InhibitorsIBA
11/2020
1Adenosine (Adenocard)FDA LinkGeneric
11/2020
1EnzymesIBA
11/2020
1Immunoconjugates (Immunoconjugate)IBA
11/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020
1Protective AgentsIBA
10/2020
1LipopolysaccharidesIBA
10/2020
1CollagenIBA
01/2020
1Thromboplastin (Tissue Factor)IBA
01/2020
1Scopolamine (Hyoscine)FDA Link
01/2020
1FibrinIBA
01/2020
1Bexarotene (LGD1069)FDA Link
01/2020
1Cholinergic Agents (Cholinergics)IBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
05/2019
1SiderophoresIBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2018
1Ubiquitin-Conjugating EnzymesIBA
01/2018
1Indicators and Reagents (Reagents)IBA
01/2018
1AlloysIBA
03/2016

Therapy/Procedure

6Therapeutics
12/2023 - 01/2019
2Immunotherapy
01/2023 - 11/2020
1Drug Therapy (Chemotherapy)
01/2021
1Intraperitoneal Injections
01/2020